JP2021521280A5 - - Google Patents

Info

Publication number
JP2021521280A5
JP2021521280A5 JP2021505625A JP2021505625A JP2021521280A5 JP 2021521280 A5 JP2021521280 A5 JP 2021521280A5 JP 2021505625 A JP2021505625 A JP 2021505625A JP 2021505625 A JP2021505625 A JP 2021505625A JP 2021521280 A5 JP2021521280 A5 JP 2021521280A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
approximately
composition according
weight
kda
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021505625A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021521280A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/027257 external-priority patent/WO2019200274A1/en
Publication of JP2021521280A publication Critical patent/JP2021521280A/ja
Publication of JP2021521280A5 publication Critical patent/JP2021521280A5/ja
Pending legal-status Critical Current

Links

JP2021505625A 2018-04-12 2019-04-12 弾性線維分解を治療するための組成物及び方法 Pending JP2021521280A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862656654P 2018-04-12 2018-04-12
US62/656,654 2018-04-12
PCT/US2019/027257 WO2019200274A1 (en) 2018-04-12 2019-04-12 Compositions and methods for treating elastic fiber breakdown

Publications (2)

Publication Number Publication Date
JP2021521280A JP2021521280A (ja) 2021-08-26
JP2021521280A5 true JP2021521280A5 (enExample) 2022-04-22

Family

ID=66323966

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021505625A Pending JP2021521280A (ja) 2018-04-12 2019-04-12 弾性線維分解を治療するための組成物及び方法

Country Status (4)

Country Link
US (4) US10933084B2 (enExample)
EP (1) EP3773614A1 (enExample)
JP (1) JP2021521280A (enExample)
WO (1) WO2019200274A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021521280A (ja) * 2018-04-12 2021-08-26 マトルクス セラピューティクス コーポレーション 弾性線維分解を治療するための組成物及び方法
CN111265590B (zh) * 2020-01-21 2022-03-01 华熙生物科技股份有限公司 一种用于鼻腔喷雾透明质酸冻干制剂及其制备方法和应用
EP4370144A1 (en) * 2021-07-14 2024-05-22 Redox-co S.r.l. Glutahtione c4 against airway affections

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA791659B (en) 1978-04-17 1980-04-30 Ici Ltd Process and apparatus for spraying liquid
US4172896A (en) 1978-06-05 1979-10-30 Dainippon Pharmaceutical Co., Ltd. Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same
GB8504253D0 (en) 1985-02-19 1985-03-20 Ici Plc Electrostatic spraying apparatus
DE3815221C2 (de) 1988-05-04 1995-06-29 Gradinger F Hermes Pharma Verwendung einer Retinol- und/oder Retinsäureester enthaltenden pharmazeutischen Zubereitung zur Inhalation zur Einwirkung auf die Schleimhäute des Tracheo-Bronchialtraktes einschließlich der Lungenalveolen
GB9217295D0 (en) 1992-08-14 1992-09-30 Wellcome Found Controlled released tablets
GB9225098D0 (en) 1992-12-01 1993-01-20 Coffee Ronald A Charged droplet spray mixer
US6105571A (en) 1992-12-22 2000-08-22 Electrosols, Ltd. Dispensing device
GB9315856D0 (en) 1993-07-30 1993-09-15 Wellcome Found Stabilized pharmaceutical
US5358970A (en) 1993-08-12 1994-10-25 Burroughs Wellcome Co. Pharmaceutical composition containing bupropion hydrochloride and a stabilizer
US5541231A (en) 1993-07-30 1996-07-30 Glaxo Wellcome Inc. Stabilized Pharmaceutical
GB9406171D0 (en) 1994-03-29 1994-05-18 Electrosols Ltd Dispensing device
GB9406255D0 (en) 1994-03-29 1994-05-18 Electrosols Ltd Dispensing device
GB9410658D0 (en) 1994-05-27 1994-07-13 Electrosols Ltd Dispensing device
IL117473A (en) 1995-03-14 2001-08-26 Siemens Ag Ultrasonic atomizer device with removable precision dosating unit
EP0814861B1 (en) 1995-03-14 2002-06-05 Siemens Aktiengesellschaft Ultrasonic atomizer device with removable precision dosing unit
US6251941B1 (en) 1996-04-19 2001-06-26 Sloan-Kettering Institute For Cancer Research Use of inhaled retinoids in the prevention of cancer
US5954047A (en) 1997-10-17 1999-09-21 Systemic Pulmonary Development, Ltd. Methods and apparatus for delivering aerosolized medication
AU2483599A (en) 1998-01-29 1999-08-16 Sepracor, Inc. Pharmaceutical uses of optically pure (-)-bupropion
GEP20043260B (en) 1998-03-16 2004-06-25 Nectar Therapeutics Aerosolized Active Agent Delivery and Device for Realization Thereof
AU2001264817A1 (en) * 2000-05-23 2001-12-17 Exhale Therapeutics, Inc. Method for treating respiratory disorders associated with pulmonary elastic fiber injury comprising the use of clycosaminoglycans
AU2002315330A1 (en) * 2001-06-15 2003-01-02 Exhale Therapeutics, Inc. Treatment of respiratory conditions associated with bronchoconstriction with aerosolized hyaluronic acid
EP1811987B1 (en) 2004-11-18 2008-04-02 Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. Dry powder comprising levothyroxine sodium administered via inhalator
ES2665254T3 (es) * 2011-07-12 2018-04-25 Holy Stone Healthcare Co., Ltd. Composiciones que comprenden ácido hialurónico para tratamiento y prevención de enfermedades relacionadas con las mucosas
US20150025019A1 (en) * 2013-07-18 2015-01-22 Jerome Owen Cantor Method for Dosage Adjustment of Drugs that Prevent Elastic Fiber Breakdown
JP2021521280A (ja) * 2018-04-12 2021-08-26 マトルクス セラピューティクス コーポレーション 弾性線維分解を治療するための組成物及び方法

Similar Documents

Publication Publication Date Title
US8263645B2 (en) Disodium cromoglycate compositions and methods for administering same
Moustafa et al. Lung deposition and systemic bioavailability of different aerosol devices with and without humidification in mechanically ventilated patients
US8709496B2 (en) Use of deuterium oxide for the treatment of virus-based diseases of the respiratory tract
JP2012503668A5 (enExample)
RU2524304C2 (ru) Применение соли ацетилсалициловой кислоты для лечения вирусных инфекций
US12246089B2 (en) Method for treatment of a viral-mediated infectious disease
Zarogoulidis et al. Experimentation with inhaled bronchodilators and corticosteroids
JP2014525471A (ja) 咳および咳発作の治療
Kaur et al. Advanced aerosol delivery devices for potential cure of acute and chronic diseases
HRP20120286T1 (hr) Kombinacija antikolinergika i inhibitora fosfodiesteraze tip 4 za liječenje respiratornih bolesti
JP2008513444A (ja) リドカイン及び他の局所麻酔剤の標的運搬並びに咳そう及び咳の発作の処置のための方法
CN115190793A (zh) 5-胺基-2,3-二氢-1,4-酞嗪二酮用于吸入性治疗发炎性肺疾病的应用
RU2012156256A (ru) Факторы трилистника (tff) для лечения хронических заболеваний легких
WO2023107977A1 (en) Methods and compositions for treating airway inflammation
Shah et al. An evaluation of two aerosol delivery systems for rhDNase
EP3773614A1 (en) Compositions and methods for treating elastic fiber breakdown
JP2008502698A5 (enExample)
CN110876723A (zh) 一种含有表面活性剂的异丙托溴铵喷雾剂
JP2024546201A5 (enExample)
WO2010009288A1 (en) Compositions and uses of antiviral active pharmaceutical agents
US9717752B2 (en) Uses of antagonists of hyaluronan signaling
WO2007046113A3 (en) Novel pharmaceutical composition comprising alkaloid and process thereof
JP2010189301A (ja) 新型インフルエンザ感染症に対する医薬組成物およびその利用
IL275328B1 (en) Methods for inducing immune tolerance and reducing antibody response against drugs
US20220202700A1 (en) Compositions for the treatment of viral pulmonary infections